Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dermapharm Holding SE

DMP
Current price
34.75 EUR +1 EUR (+2.96%)
Last closed 34 EUR
ISIN DE000A2GS5D8
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange XETRA Stock Exchange
Capitalization 1 738 699 581 EUR
Yield for 12 month -10.44 %
1Y
3Y
5Y
10Y
15Y
DMP
21.11.2021 - 28.11.2021

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG. Address: Lil-Dagover-Ring 7, Grünwald, Germany, 82031

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

47.04 EUR

P/E ratio

20.7468

Dividend Yield

5.2 %

Current Year

+1 147 568 912 EUR

Last Year

+1 035 803 975 EUR

Current Quarter

+282 813 048 EUR

Last Quarter

+301 905 319 EUR

Current Year

+346 550 648 EUR

Last Year

+667 944 456 EUR

Current Quarter

+81 484 548 EUR

Last Quarter

+111 358 610 EUR

Key Figures DMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 219 933 584 EUR
Operating Margin TTM 10.03 %
PE Ratio 20.7468
Return On Assets TTM 5.71 %
PEG Ratio
Return On Equity TTM 15 %
Wall Street Target Price 47.04 EUR
Revenue TTM 1 159 035 029 EUR
Book Value 10.33 EUR
Revenue Per Share TTM
Dividend Share 0.89 EUR
Quarterly Revenue Growth YOY 6.5 %
Dividend Yield 5.2 %
Gross Profit TTM 655 684 932 EUR
Earnings per share 1.56 EUR
Diluted Eps TTM 1.56 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -12 %
Profit Margin 7.24 %

Dividend Analytics DMP

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

55 %

Dividend History DMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.88
Ex Dividend Date 28.06.2024
Forward Annual Dividend Yield 2.79 %
Last Split Factor
Payout Ratio 1.63 %
Last Split Date
Dividend Date

Stock Valuation DMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.7468
Forward PE 16.4474
Enterprise Value Revenue 2.2812
Price Sales TTM 1.5001
Enterprise Value EBITDA 8.9735
Price Book MRQ 3.0797

Financials DMP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DMP

For 52 weeks

29.69 EUR 41.66 EUR
50 Day MA 33.13 EUR
Shares Short Prior Month
200 Day MA 35.3 EUR
Short Ratio
Shares Short
Short Percent